Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureMarkus Sebastian Jördens, Kathrine Sivertsen Nordhus, Jonas Øgaard, Enya Amundsen-Isaksen, Oda Helgesen Ramberg, Wen Jie Yeoh, Kristian Holm, Xiaojun Jiang, Tom Luedde, Tom H. Karlsen, Brian K. Chung, Espen Melum
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Primary sclerosing cholangitis - a comprehensive review
10.1016/j.jhep.2017.07.022 · 2017
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review
10.1016/j.jhep.2011.10.025 · 2012
Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
10.1038/ctg.2015.33 · 2015
Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis
10.1111/apt.12581 · 2014
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci
10.1038/ng.728 · 2011
Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis
10.1002/hep.24299 · 2011
The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review
10.1055/s-0039-1697617 · 2020
Cholangiocyte pathobiology
10.1038/s41575-019-0125-y · 2019
Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials
10.1111/j.1572-0241.2006.00634.x · 2006
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group
10.1056/nejm199405123301903 · 1994
Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid
10.1053/j.gastro.2014.12.005 · 2015
NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis
10.1084/jem.20051911 · 2006
Animal models in primary biliary cirrhosis and primary sclerosing cholangitis
10.1007/s12016-014-8442-y · 2015
The role of natural killer T cells in a mouse model with spontaneous bile duct inflammation
10.14814/phy2.13117 · 2017
A Novel Pkhd1 Mutation Interacts with the Nonobese Diabetic Genetic Background To Cause Autoimmune Cholangitis
10.4049/jimmunol.1701087 · 2018
The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation
10.1016/j.jhep.2016.09.020 · 2017
DIRECTIVE 2010/63/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 22 September 2010 on the protection of animals used for scientific purposes
2010
Unresolved referenced work
Kept as external metadata until matched
Evaluation of differential gene expression by microarray analysis in small and large cholangiocytes isolated from normal mice
10.1111/j.1478-3231.2003.00876.x · 2003
Tissue-specific recognition of mouse CD1 molecules
10.4049/jimmunol.160.7.3128 · 1998
Spatial transcriptomics identifies enriched gene expression and cell types in human liver fibrosis
10.1002/hep4.2001 · 2022
Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver
10.1016/j.isci.2021.103233 · 2021
Spatially informed cell-type deconvolution for spatial transcriptomics
10.1038/s41587-022-01273-7 · 2022
QuPath: Open source software for digital pathology image analysis
10.1038/s41598-017-17204-5 · 2017
Single-cell reconstruction of the early maternal-fetal interface in humans
10.1038/s41586-018-0698-6 · 2018
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
10.1038/ng.2616 · 2013
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs
10.1016/j.jhep.2021.04.055 · 2021
Cholangiocytes Modulate CD100 Expression in the Liver and Facilitate Pathogenic T-Helper 17 Cell Differentiation
10.1053/j.gastro.2023.11.283 · 2024
TIGIT can inhibit T cell activation via ligation-induced nanoclusters, independent of CD226 co-stimulation
10.1038/s41467-023-40755-3 · 2023
The biliary epithelium presents antigens to and activates natural killer T cells
10.1002/hep.27840 · 2015
Inhibition of CD226 co-stimulation suppresses diabetes development in the NOD mouse by augmenting regulatory T cells and diminishing effector T cell function
10.1007/s00125-024-06329-8 · 2025
New Treatment Paradigms in Primary Biliary Cholangitis
10.1016/j.cgh.2023.02.005 · 2023
Recent Advances in the Management of Primary Sclerosing Cholangitis
10.1016/j.cgh.2023.04.004 · 2023
Characterization of animal models for primary sclerosing cholangitis (PSC)
10.1016/j.jhep.2014.02.006 · 2014
TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors
10.1084/jem.161.5.1063 · 1985
DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes
10.1016/s1074-7613(00)70060-4 · 1996
CD226: An Emerging Role in Immunologic Diseases
10.3389/fcell.2020.00564 · 2020
Low expression of CD112 is associated with poor overall survival in patients with hepatocellular carcinoma
10.1016/j.humpath.2014.06.001 · 2014
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)
10.1182/blood-2004-09-3548 · 2005
Emergence of the CD226 Axis in Cancer Immunotherapy
10.3389/fimmu.2022.914406 · 2022
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis
10.1126/scitranslmed.abb0036 · doi-reference
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
10.1084/jem.20030788 · doi-reference
Association between the CTLA-4, CD226, FAS polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis
10.1016/j.humimm.2015.01.023 · doi-reference
Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell function
10.1093/brain/awv256 · doi-reference
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
10.1038/ng2068 · doi-reference